The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Review Article
Mechanisms of Disease
PreviousPrevious
Volume 361:2066-2078 November 19, 2009 Number 21
NextNext

Inflammatory Bowel Disease
Clara Abraham, M.D., and Judy H. Cho, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-PowerPoint Slide Set
-CME Exam
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
The idiopathic inflammatory bowel diseases comprise two types of chronic intestinal disorders: Crohn's disease and ulcerative colitis. Accumulating evidence suggests that inflammatory bowel disease results from an inappropriate inflammatory response to intestinal microbes in a genetically susceptible host. Genetic studies highlight the importance of host–microbe interactions in the pathogenesis of these diseases.1,2,3,4,5,6,7,8,9,10,11,12,13 Prominent among these genetic findings are genomic regions containing nucleotide oligomerization domain 2 (NOD2),14 autophagy genes,4,7,8,10 and components of the interleukin-23–type 17 helper T-cell (Th17) pathway.2 The NOD2 protein is an intracellular sensor of bacterial peptidoglycan, and autophagy enables cells to regulate and degrade diverse intracellular components, including . . . [Full Text of this Article]

The Intestinal Immune System

The Intestinal Microbiome and Inflammatory Bowel Disease

The Intestinal Epithelium

The Inflammatory Response in Inflammatory Bowel Disease

Innate Immune Recognition

CD4+ T Cells

B Cells

Intestinal Vasculature and Leukocyte Migration

Innate-Immune-Response Genes and Crohn's Disease

NOD2 and Crohn's Disease

Autophagy Genes and Crohn's Disease

Adaptive Immunity and Inflammatory Bowel Disease

Alterations in T-Cell Tolerance

Th17 Cells and Interleukin-23 Signaling in Inflammatory Bowel Disease

Comparative Gene Association Studies in Crohn's Disease and Ulcerative Colitis

Therapeutic Implications


Source Information

From the Department of Internal Medicine, Section of Digestive Diseases, and Department of Genetics, Yale University School of Medicine, New Haven, CT.

Address reprint requests to Dr. Cho at the Yale University School of Medicine, 333 Cedar St., 1080 LMP, New Haven, CT 06520, or at judy.cho@yale.edu or clara.abraham@yale.edu.




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2010 Massachusetts Medical Society. All rights reserved.